Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6UUD | 6UUD | Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide | |
| 6UTK | 6UTK | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
| 6USF | 6USF | CryoEM structure of human alpha4beta2 nicotinic acetylcholine receptor with varenicline in complex with anti-BRIL synthetic antibody BAK5 | |
| 6URM | 6URM | Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 | |
| 6URH | 6URH | Crystal structure of broadly neutralizing antibody AR3X in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 6UR5 | 6UR5 | Resurfaced influenza hemagglutinin in complex with a broadly neutralizing antibody | |
| 6UQR | 6UQR | Complex of IgE and Ligelizumab | |
| 6UM7 | 6UM7 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | |
| 6UM6 | 6UM6 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | |
| 6UM5 | 6UM5 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | |
| 6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | |
| 6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | |
| 6UJF | 6UJF | Crystal structure of the Clostridial cellulose synthase subunit Z (CcsZ) from Clostridioides difficile | |
| 6UJC | 6UJC | Integrin alpha-v beta-8 in complex with the Fabs C6-RGD3 and 11D12v2 | |
| 6UJB | 6UJB | Integrin alpha-v beta-8 in complex with the Fabs C6D4 and 11D12v2 | |
| 6UIG | 6UIG | Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1 | |
| 6UIB | 6UIB | Crystal structure of IL23 bound to peptide 23-652 | |
| 6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
| 6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
| 6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
| 6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
| 6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
| 6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
| 6UG9 | 6UG9 | Complex of ch28/11 Fab and SSEA-4 (hexagonal form) | |
| 6UG8 | 6UG8 | Complex of ch28/11 Fab and SSEA-4 (monoclinic form) | |
| 6UG7 | 6UG7 | Complex of ch28/11 Fab and SSEA-4 (tetragonal form) | |
| 6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | |
| 6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | |
| 6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | |
| 6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | |
| 6UDA | 6UDA | Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 | |
| 6U7H | 6U7H | Cryo-EM structure of the HCoV-229E spike glycoprotein | |
| 6U7F | 6U7F | HCoV-229E RBD Class IV in complex with human APN | |
| 6U7E | 6U7E | HCoV-229E RBD Class III in complex with human APN | |
| 6U6U | 6U6U | IL36R extracellular domain in complex with BI655130 Fab | |
| 6U59 | 6U59 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6U59 | 6U59 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | |
| 6U3O | 6U3O | JR51 DQ2-p.aeru-alpha2a complex | |
| 6U3N | 6U3N | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | |
| 6U3M | 6U3M | DQ2-P.fluor-alpha1a | |
| 6U0N | 6U0N | Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | |
| 6U0L | 6U0L | Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | |
| 6U02 | 6U02 | CryoEM-derived model of NA-63 Fab in complex with N9 Shanghai2 | |
| 6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
| 6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | |
| 6TYB | 6TYB | Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields | |
| 6TSM | 6TSM | Marasmius oreades agglutinin (MOA) in complex with the truncated PVVRAHS synthetic substrate | |
| 6TSL | 6TSL | Marasmius oreades agglutinin (MOA) in complex with the truncated PVPRAHS synthetic substrate | |
| 6TMK | 6TMK | Cryo-EM structure of Toxoplasma gondii mitochondrial ATP synthase dimer, composite model | ATPTG11, ATPTG7, ATPTG14, Uncharacterized protein, subunit k, subunit a, subunit i/j, Putative membrane protein, ATPTG15, ATPTG6, ATPTG3, ATPTG17, subunit b, ATPTG12, ATPTG10, subunit f, Putative myosin heavy chain, Cytochrome c1, heme protein, ATPTG2, subunit 8, ATPTG9, Thioredoxin domain-containing protein, ATPTG16, subunit d, Inhibitor of F1, ATP synthase subunit alpha,subunit alpha, ATP synthase subunit beta (E.C.7.1.2.2), ATP synthase F1 gamma subunit, Putative ATP synthase, Putative atp synthase F1, epsilon subunit, ATP synthase F1, delta subunit protein, Putative ATP synthase F0 subunit 9 |
| 6TMK | 6TMK | Cryo-EM structure of Toxoplasma gondii mitochondrial ATP synthase dimer, composite model | ATPTG11, ATPTG7, ATPTG14, Uncharacterized protein, subunit k, subunit a, subunit i/j, Putative membrane protein, ATPTG15, ATPTG6, ATPTG3, ATPTG17, subunit b, ATPTG12, ATPTG10, subunit f, Putative myosin heavy chain, Cytochrome c1, heme protein, ATPTG2, subunit 8, ATPTG9, Thioredoxin domain-containing protein, ATPTG16, subunit d, Inhibitor of F1, ATP synthase subunit alpha,subunit alpha, ATP synthase subunit beta (E.C.7.1.2.2), ATP synthase F1 gamma subunit, Putative ATP synthase, Putative atp synthase F1, epsilon subunit, ATP synthase F1, delta subunit protein, Putative ATP synthase F0 subunit 9 |
